Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32,371 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node-positive bladder cancer: A retrospective analysis: KCSG GU 17-03.
Bae WK, Lee HJ, Park SH, Kim JH, Kim HJ, Maeng CH, Park I, Sohn BS, Kim JA, Lee KH, Lim DH, Chang H, Kim SM, Kim HY, Song H, Lim S, Byun JH, Jung HA. Bae WK, et al. Among authors: kim hy, kim hj, kim ja, kim sm, kim jh. Cancer Med. 2019 Sep;8(12):5431-5437. doi: 10.1002/cam4.2446. Epub 2019 Jul 29. Cancer Med. 2019. PMID: 31353788 Free PMC article.
Predictive value of the ERCC1 expression for treatment response and survival in advanced gastric cancer patients receiving cisplatin-based first-line chemotherapy.
Yun J, Kim KM, Kim ST, Kim JH, Kim JA, Kong JH, Lee SH, Won YW, Sun JM, Lee J, Park SH, Park JO, Park YS, Lim HY, Kang WK. Yun J, et al. Among authors: kim st, kim km, kim ja, kim jh. Cancer Res Treat. 2010 Jun;42(2):101-6. doi: 10.4143/crt.2010.42.2.101. Epub 2010 Jun 30. Cancer Res Treat. 2010. PMID: 20622964 Free PMC article.
A dose-finding study for oxaliplatin, irinotecan, and S-1 (OIS) in patients with metastatic or recurrent gastrointestinal cancer.
Han B, Jung JY, Kim HS, Cho JW, Kim KC, Lim H, Kang HS, Ha HI, Kim MJ, Kim JH, Choi DR, Jang G, Kim JH, Song H, Zang DY. Han B, et al. Among authors: kim kc, kim hs, kim mj, kim jh. Cancer Chemother Pharmacol. 2016 Nov;78(5):949-958. doi: 10.1007/s00280-016-3147-y. Epub 2016 Sep 15. Cancer Chemother Pharmacol. 2016. PMID: 27628195 Clinical Trial.
Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial.
Lee J, Kim ST, Kim K, Lee H, Kozarewa I, Mortimer PGS, Odegaard JI, Harrington EA, Lee J, Lee T, Oh SY, Kang JH, Kim JH, Kim Y, Ji JH, Kim YS, Lee KE, Kim J, Sohn TS, An JY, Choi MG, Lee JH, Bae JM, Kim S, Kim JJ, Min YW, Min BH, Kim NKD, Luke S, Kim YH, Hong JY, Park SH, Park JO, Park YS, Lim HY, Talasaz A, Hollingsworth SJ, Kim KM, Kang WK. Lee J, et al. Among authors: kim yh, kim jj, kim nkd, kim st, kim km, kim s, kim ys, kim j, kim y, kim k, kim jh. Cancer Discov. 2019 Oct;9(10):1388-1405. doi: 10.1158/2159-8290.CD-19-0442. Epub 2019 Jul 17. Cancer Discov. 2019. PMID: 31315834
32,371 results
You have reached the last available page of results. Please see the User Guide for more information.